Sanofi starts dengue vaccine production to keep lead over rivals
By Catherine Lagrange NEUVILLE-SUR-SAONE, France (Reuters) - Sanofi SA has started producing its experimental dengue vaccine, the most advanced against the tropical disease, in a move to keep its lead over competitors ahead of the product's likely launch in 2015. The mosquito-borne disease is a threat to nearly 3 billion people and is caused by four types of virus, none of which confers immunity from the others. Sanofi's vaccine could generate sales of over $1 billion if successful. ...
See Also
http://wiki.fachschaftsrat.info/index.php?title=Are_You_Searching_Frantically_For_Helpful_Advice_On_Slimming_Pills
http://www.43things.com/entries/view/5967172
http://www.afrocubanos.net/blogs/viewstory/434
http://wiki.montanaecosmart.com/wiki/The_Benefits_Of_Weight_Loss_Supplements
http://wuluri.soup.io/post/314742118/Effective-Weight-Loss-Tips
http://my.mors.by/blogs/7931/18502/the-actual-facts-concerning-effe
No comments:
Post a Comment